Search Results

contribute to the implementation of the guidelines, together improving translation from in vitro to disease-relevant

pharmacological effects in the treatment of several neurological disorders including, epilepsy, Parkinson’s disease , and Alzheimer’s disease.

Although blockade of GPR84 may potentially prove effective also in diseases associated with inflammation

study in Q1 2023 and continue to evaluate the path forward for dipraglurant in a number of interesting disease

Sir William Osler Scientists have long sought to discover a “golden bullet” that would cure every disease The more we know about the pathology of diseases, the more complicated it is to modulate them by a specific The choice of pathway can result in different cellular responses, underscoring the criticality of precise

sites of GPCRs for drug discovery Targeting mGluR group III for the treatment of neurodegenerative diseases Methods & Updates in GPCR Research Advancements in the use of xenopus oocytes for modelling neurological disease

protein-coupled receptor (GPCR) kinases (GRKs) are associated with the pathophysiology of Alzheimer's disease

important drug targets, and numerous drugs that modulate GPCRs are already in clinical use for various diseases Drug repurposing: AI algorithms can screen existing drugs and repurpose them for GPCR-related diseases By analyzing drug-target interactions and disease pathways, AI can identify potential candidates that Towards a comprehensive understanding of GPCRs, ligands, diseases, and their associations: open-access

Neuroscience Diverse signaling mechanisms and heterogeneity of astrocyte reactivity in Alzheimer's disease Sosei Heptares and Kallyope Nominate First GPCR Target for Therapeutic Development in Gastrointestinal Diseases

intracellular protein complexes and solute carriers, are relevant to immunology indications and rare diseases

conformationally selective VHH antibodies – ConfoBodies® – to stabilize GPCRs (G protein-coupled receptors) in disease-relevant

GPCRs in Cardiology, Endocrinology, and Taste Gender Differences in GRK2 in Cardiovascular Diseases and Manager Director of Molecular Pharmacology, Discovery Biology Staff Scientist/Senior Staff Scientist, Disease

protein-coupled A2A adenosine receptor (A2AAR) have been considered promising agents to treat Parkinson's disease

Neisseria meningitidis is a Gram-negative opportunistic pathogen that is responsible for causing human diseases

cellulose-degrading enzymes Functional Water Channels Within the TSH Receptor - a new paradigm for TSH action with disease launch LAB eN², a translational drug discovery accelerator, to address innovation gap in cardiometabolic diseases

knockdown regulates the expression and alternative splicing of genes associated with aphasia-related diseases ochraceus quorum sensing through the GprC-AcyA pathway Deciphering the genetic landscape of lumpy skin disease

numerous GPCRs have been studied for their impact on pathologic conditions, including cardiovascular diseases

with the fact that dysregulation of compartmentalized GPCR signaling has been implicated in various diseases aberrant endosomal signaling by GPCRs has been linked to disorders such as cancer, neurodegenerative diseases Insights into Nuclear G-Protein-Coupled Receptors as Therapeutic Targets in Non-Communicable Diseases

Retinitis pigmentosa (RP) is a group of hereditary degenerative diseases affecting 1 of 4000 people worldwide

Several S1PR therapeutic drugs have been developed to treat these diseases; however, they lack receptor

Portal Venous Blood as a Possible Mechanism for Microbiota Effects on the Immune System, and Western Diseases concept to metabolomics: New insights into pregnenolone function Molecular characterization of lumpy skin disease

effects of CB2 receptor activation, make this receptor an intriguing target for treating schizophrenia, a disease

(GPCR) targets with a goal of creating new drug discovery programs in the area of gastrointestinal diseases

Modulation of GPCR receptors common to gut inflammatory diseases and neuronal disorders, Alzheimer's and Parkinson's diseases as druggable targets through Withania somnifera bioactives: an in silico study

phases of clinical development, and across multiple therapeutic areas, including Oncology, Infectious Diseases

plant-like” behavior in important human cell regulator, opening up a new drug target for cancer, other diseases Neuroscience Diverse signaling mechanisms and heterogeneity of astrocyte reactivity in Alzheimer's disease

protein-coupled receptors (aGPCRs) are keys of many physiological events and attractive targets for various diseases

fluorescent GPCR ligands "G-protein coupled receptors (GPCRs) have been largely targeted in a wide range of diseases